Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden

Abstract

Previous studies have yielded conflicting results as to the putative role of the functional polymorphism of the promoter region of the serotonin transporter gene (SLC6A4) in the etiology of anxiety-related traits and depressive disorders. Recently, a significant gene–environment interaction was found between life stressors, the short allele of the SLC6A4 polymorphism and depression. The aim of the present study was to investigate if such a gene–environment interaction could be replicated within a different population with a different risk structure. A total of 1005 subjects from a general population sample (Study of Health in Pomerania) were genotyped. Mental and physical distress were assessed on 38 items of the modified complaint scale (BL-38). The interaction between the SLC6A4 genotype, social stressors and chronic diseases with regard to the BL-38 score was evaluated by ANOVA. There was no independent association of genotype with mental and physical distress. However, significant interactions between genotype, unemployment and chronic diseases (F=6.6; df=3, 671; P<0.001) were found in females but not in males. The genotype explained 2% of the total variance of the BL-38 score and 9.1% of the explained variance. The results partly confirm previous findings of a significant gene–environment interaction of the short allele, indicating a higher mental vulnerability to social stressors and chronic diseases. The relevance of this finding is sustained by the fact that the sample characteristics and the risk structure were highly different from previous studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624.

    Article  CAS  Google Scholar 

  2. Heils A, Mossner R, Lesch KP . The human serotonin transporter gene polymorphism: basic research and clinical implications. J Neural Transm 1997; 104: 1005–1014.

    Article  CAS  Google Scholar 

  3. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155: 207–213.

    Article  CAS  Google Scholar 

  4. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996; 1: 453–460.

    CAS  Google Scholar 

  5. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83–87.

    Article  CAS  Google Scholar 

  6. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.

    Article  CAS  Google Scholar 

  7. Cloninger CR, Przybeck TR, Svrakic DM . The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep 1991; 69: 1047–1057.

    Article  CAS  Google Scholar 

  8. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 2000; 96: 202–216.

    Article  CAS  Google Scholar 

  9. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M et al. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998; 55: 936–940.

    Article  CAS  Google Scholar 

  10. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH . No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2: 224–226.

    Article  CAS  Google Scholar 

  11. Flory JD, Munack SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF . Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 1999; 4: 93–96.

    Article  CAS  Google Scholar 

  12. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B et al. An association study of a functional polymorphism of the serotinin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 1998; 3: 449–451.

    Article  CAS  Google Scholar 

  13. Lesch KP In: Plomin R, DeFries JC, Craig IW, McGuffin P (eds). Behavioural Genetics in the Postgenomics Era. APA: Washington, DC, 2003 pp 389–424.

    Book  Google Scholar 

  14. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002; 59: 613–620.

    Article  CAS  Google Scholar 

  15. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 18: 386–389.

    Article  Google Scholar 

  16. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S et al. Study of health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz-Präventivmed 2001; 46: 186–194.

    Article  CAS  Google Scholar 

  17. von Zerssen D, Koeller D . Beschwerden-Liste (Complaints Schedule). Beltz: Weinheim, 1976.

    Google Scholar 

  18. Bauer M, Priebe S, Berghofer A, Bschor T, Kiesslinger U, Whybrow PC . Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders. J Affect Disord 2001; 64: 35–42.

    Article  CAS  Google Scholar 

  19. Baltes PB, Mayer KU (eds). The Berlin Aging Study: Aging From 70 to 100. Cambridge University Press: New York, 1999.

    Google Scholar 

  20. Sherbourne CD, Stewart AL . The MOS Social Support Survey. Social Sci Med 1991; 32: 705–714.

    Article  CAS  Google Scholar 

  21. McDowell I, Newell C . Measuring health. A guide to rating scales and questionnaires. Oxford University Press: New York, 1996.

    Google Scholar 

  22. Brummett BH, Siegler IC, McQuoid DR, Svenson IK, Marchuk DA, Steffens DC . Associations among the NEO personality inventory, revised and the serotonin transporter gene-linked polymorphic region in elders: effect of depression and gender. Psychiatr Genet 2003; 13: 13–18.

    Article  Google Scholar 

  23. Kruth HS . Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 1985; 227: 1243–1245.

    Article  CAS  Google Scholar 

  24. Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J et al. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation 1989; 79: 154–166.

    Article  CAS  Google Scholar 

  25. Vikenes K, Farstad M, Nordrehaug JE . Serotonin is associated with coronary artery disease and cardiac events. Circulation 1999; 100: 483–489.

    Article  CAS  Google Scholar 

  26. Arinami T, Ohtsuki T, Yamakawa-Kobayashi K, Amemiya H, Fujiwara H, Kawata K et al. A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999; 81: 853–856.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research work was funded in part by grants from the German Federal Ministry for Education and Research (BMBF, grant no. 01ZZ96030), from the Ministry for Education, Research and Cultural Affairs and the Ministry for Social Affairs of the State Mecklenburg-Western Pomerania. Laboratory work was supported by a grant to HJG from the Research Foundation for Neuroscience of the University of Greifswald.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H J Grabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grabe, H., Lange, M., Wolff, B. et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10, 220–224 (2005). https://doi.org/10.1038/sj.mp.4001555

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001555

Keywords

This article is cited by

Search

Quick links